(Health-NewsWire.Net, September 22, 2016 ) Cirrhosis of the liver (or liver fibrosis) is a serious condition in which the liver stops functioning properly due to damage and irreversible scarring of the liver tissue. The scarring of the tissue is often caused by long-term exposure to viral infections and toxins such as alcohol. Chronic viral hepatitis and non-alcoholic steatohepatitis can also cause liver cirrhosis. Alcohol-related medications, antiviral medications, and metal chelating agents are used in the treatment of the causes of liver cirrhosis while antibiotics, vitamins, corticosteroids, diuretics, beta-blockers, and laxatives are used for the treatment of the complications of the disease.
Publisher's analysts forecast the global liver cirrhosis therapeutics market to grow at a CAGR of 4.36% during the period 2016-2020. For more information about this report: http://www.reportsweb.com/global-liver-cirrhosis-market-2016-2020 . The report covers the present scenario and the growth prospects of the global liver cirrhosis therapeutics market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of prescription, generic, and off-label drugs used in the treatment of liver cirrhosis.
The market is divided into the following segments based on geography: - Americas - APAC - EMEA
Publisher's report, Global Liver Cirrhosis Therapeutics Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Make an enquiry: http://www.reportsweb.com/inquiry&RW0001236138/buying .
Key vendors - F Hoffman La-Roche - GlaxoSmithKline - Gilead Sciences - Johnson & Johnson - Merck
Other prominent vendors - Bristol-Myers Squibb - Conatus Pharmaceuticals - Gwo Xi Stem Cell Applied Technology - Instituto Grifols - Intercept Pharmaceuticals - NGM Biopharmaceuticals - Norgine - Pharmicell - Salix Pharmaceuticals - Stempeutics Research
Market driver - High prevalence of liver cirrhosis - For a full, detailed list, view our report
Market challenge - Adverse effects of drugs - For a full, detailed list, view our report
Market trend - Use of off-label drugs - For a full, detailed list, view our report
Buy this Report: http://www.reportsweb.com/buy&RW0001236138/buy/2500 .
ReportsWeb.com
Priya Sisodia
+1-646-491-9876
sales@reportsweb.com
Source: EmailWire.Com
|